Financial Times Healthcare
Conflicted interests
The fact that scientists receive funding from companies does not mean they should be excluded from policy debates and the drafting of guidelines
Conflicted interests
The fact that scientists receive funding from companies does not mean they should be excluded from policy debates and the drafting of guidelines
Four Seasons close to renegotiating its debt
Four Seasons Health Care is close to sealing a second-round renegotiation on the terms of its £600m of debt as a majority of lenders agreed to back its latest restructuring plan
Four Seasons close to renegotiating its debt
Four Seasons Health Care is close to sealing a second-round renegotiation on the terms of its £600m of debt as a majority of lenders agreed to back its latest restructuring plan
East offers prescription for west's plans
Western companies have been tempted by strong sales of their older medicines, as well as a willingness by the Chinese authorities to authorise western prices for innovative drugs
East offers prescription for west's plans
Western companies have been tempted by strong sales of their older medicines, as well as a willingness by the Chinese authorities to authorise western prices for innovative drugs
Chinese pharma finds partner in India
Desano, a Shanghai-based pharmaceutical company, is building factories to produce complex biological drugs such as cancer treatments with funding and support from Indian group Cipla
Chinese pharma finds partner in India
Desano, a Shanghai-based pharmaceutical company, is building factories to produce complex biological drugs such as cancer treatments with funding and support from Indian group Cipla
China medicine proves tonic for investors
Traditional Chinese medicine, which is attracting businesses and investors domestically and abroad, has grown from 1% to 11% of the local pharmaceuticals market
China medicine proves tonic for investors
Traditional Chinese medicine, which is attracting businesses and investors domestically and abroad, has grown from 1% to 11% of the local pharmaceuticals market
Judge rules FTC did not improperly pressure Watson
A federal magistrate judge largely exonerated the Federal Trade Commission's actions in a long-running legal dispute with Watson Pharmaceuticals after previously raising questions about whether the consumer protection watchdog had put improper pressure on the generic drugmaker
Judge rules FTC did not improperly pressure Watson
A federal magistrate judge largely exonerated the Federal Trade Commission's actions in a long-running legal dispute with Watson Pharmaceuticals after previously raising questions about whether the consumer protection watchdog had put improper pressure on the generic drugmaker
AZ staff to strike over pensions
Workers at one of AstraZeneca's largest plants in the UK have voted for strike action if the pharmaceutical group refuses to backtrack on plans to freeze its final salary pension scheme
AZ staff to strike over pensions
Workers at one of AstraZeneca's largest plants in the UK have voted for strike action if the pharmaceutical group refuses to backtrack on plans to freeze its final salary pension scheme
German health reformers face political pitfalls
With prices for new drugs and instruments rising and more people living longer, Germany's four-lane healthcare system seems to be getting precariously expensive
German health reformers face political pitfalls
With prices for new drugs and instruments rising and more people living longer, Germany's four-lane healthcare system seems to be getting precariously expensive
Insurer-based system delivers, at a price
The Dutch have kept general practitioners as "gatekeepers" who control access to specialists by referring patients. But rather than a "postcode lottery" for healthcare resources, insurance companies, who have contracts with health providers, compete to provide care.
Insurer-based system delivers, at a price
The Dutch have kept general practitioners as "gatekeepers" who control access to specialists by referring patients. But rather than a "postcode lottery" for healthcare resources, insurance companies, who have contracts with health providers, compete to provide care.
Novartis's war of nerves with Alcon rages on
The replacement of five Nestlé-nominated directors for five nominees from the Swiss pharmaceuticals group is unlikely to mark the end of the story
Novartis's war of nerves with Alcon rages on
The replacement of five Nestlé-nominated directors for five nominees from the Swiss pharmaceuticals group is unlikely to mark the end of the story
